The University of Texas MD Anderson Cancer Center and Myriad Genetics, Inc. today announced a five-year strategic alliance to accelerate the clinical evaluation and development of Myriad’s molecular residual disease (MRD) assay.
Pfizer to cut 500 jobs at Sandwich, UK site
Another 500 jobs are on the chopping block as a result of Pfizer’s cost-cutting measures, this time at the company’s site in Sandwich, UK, where